Zobrazeno 1 - 10
of 31
pro vyhledávání: '"De Cecco, Loris"'
Autor:
Casanova M; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milan, Italy., Pontis F; Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milan, Italy., Ghidotti P; Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milan, Italy., Petraroia I; Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milan, Italy., Venturini LV; Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milan, Italy., Bergamaschi L; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milan, Italy., Chiaravalli S; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milan, Italy., De Cecco L; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milan, Italy., Massimino M; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milan, Italy., Sozzi G; Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milan, Italy., Ferrari A; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milan, Italy., Fortunato O; Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milan, Italy., Gasparini P; Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2022 Nov 13; Vol. 23 (22). Date of Electronic Publication: 2022 Nov 13.
Autor:
Pizzamiglio S; Bioinformatics and Biostatistics Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cosentino G; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ciniselli CM; Bioinformatics and Biostatistics Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Integrated Biology Platform, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cataldo A; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Plantamura I; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Triulzi T; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., El-Abed S; Breast International Group (BIG), Brussels, Belgium., Wang Y; Novartis Pharma AG, Basel, Switzerland., Bajji M; Institute Jules Bordet (IJB), Brussels, Belgium., Nuciforo P; Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Huober J; Breast Center, Cantonal Hospital, St. Gallen, Switzerland., Ellard SL; BC Cancer, Kelowna, British Columbia, Canada., Rimm DL; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA., Gombos A; Institute Jules Bordet (IJB), Brussels, Belgium., Daidone MG; Biomarkers Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Verderio P; Bioinformatics and Biostatistics Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tagliabue E; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Di Cosimo S; Biomarkers Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Iorio MV; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Cancer medicine [Cancer Med] 2022 Jan; Vol. 11 (2), pp. 332-339. Date of Electronic Publication: 2021 Dec 17.
Autor:
Ditto A; Unit of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., De Cecco L; Department of Applied Research and Technology Development, Integrated Biology Platform, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Paolini B; Department of Pathology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Alberti P; Department of Research, Unit of Molecular Therapies, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Martinelli F; Unit of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Leone Roberti Maggiore U; Unit of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Bogani G; Unit of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Chiodini P; Medical Statistics Unit, University of Campania 'Luigi Vanvitelli', Naples, Italy., Pignata S; Urogynaecological Medical Oncology Unit, Istituto Nazionale Tumori - IRCCS - 'Fondazione G. Pascale', Naples, Italy., Tomassetti A; Department of Research, Unit of Molecular Therapies, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Raspagliesi F; Unit of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Mezzanzanica D; Department of Research, Unit of Molecular Therapies, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. Electronic address: delia.mezzanzanica@istitutotumori.mi.it., Bagnoli M; Department of Research, Unit of Molecular Therapies, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Jan; Vol. 161, pp. 55-63. Date of Electronic Publication: 2021 Dec 15.
Autor:
Colombo C; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.; Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy., Minna E; Department of Research, Molecular Mechanisms Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gargiuli C; Department of Applied Research and Technology Development, Platform of Integrated Biology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Muzza M; Laboratory of Endocrine and Metabolic Research, IRCCS Istituto Auxologico Italiano, Milan, Italy., Dugo M; Department of Applied Research and Technology Development, Platform of Integrated Biology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Department of Applied Research and Technology Development, Platform of Integrated Biology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pogliaghi G; Laboratory of Endocrine and Metabolic Research, IRCCS Istituto Auxologico Italiano, Milan, Italy., Tosi D; Department of Health Sciences, Division of Human Pathology, Università degli Studi di Milano, Milan, Italy., Bulfamante G; Department of Health Sciences, Division of Human Pathology, Università degli Studi di Milano, Milan, Italy., Greco A; Department of Research, Molecular Mechanisms Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fugazzola L; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy. laura.fugazzola@unimi.it.; Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy. laura.fugazzola@unimi.it., Borrello MG; Department of Research, Molecular Mechanisms Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. MariaGrazia.Borrello@istitutotumori.mi.it.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2020 Nov 16; Vol. 39 (1), pp. 245. Date of Electronic Publication: 2020 Nov 16.
Autor:
Siano M; Cantonal Hospital St. Gallen, Dept. of Med. Oncology and Hematology, Rorschacherstrasse 95, CH-9007 St. Gallen, Switzerland. Electronic address: marco.siano@kssg.ch., Espeli V; Oncology Institute of Southern Switzerland, San Giovanni Hospital, CH-6500 Bellinzona, Switzerland. Electronic address: vittoria.espeli@eoc.ch., Mach N; Oncology Centre, Clinical Research Unit DFDL, University Hospital, CH-1205 Geneva, Switzerland. Electronic address: nicolas.mach@hcuge.ch., Bossi P; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy. Electronic address: paolo.bossi@istitutotumori.mi.it., Licitra L; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy; State University of Milan, Via Festa del Perdono, 7, I-20122 Milano, Italy. Electronic address: lisa.licitra@istitutotumori.mi.it., Ghielmini M; Oncology Institute of Southern Switzerland, San Giovanni Hospital, CH-6500 Bellinzona, Switzerland. Electronic address: michele.ghielmini@eoc.ch., Frattini M; Institute of Pathology, Laboratory of Molecular Pathology, CH-6600 Locarno, Switzerland. Electronic address: milo.frattini@ti.ch., Canevari S; Fondazione IRCCS Istituto Nazionale dei Tumori, Integrated Biology Platform, Department of Applied Research and Technology Development, Via Amadeo 42, I-20133 Milan, Italy. Electronic address: silvana.canevari@istitutotumori.mi.it., De Cecco L; Fondazione IRCCS Istituto Nazionale dei Tumori, Integrated Biology Platform, Department of Applied Research and Technology Development, Via Amadeo 42, I-20133 Milan, Italy. Electronic address: loris.dececco@istitutotumori.mi.it.
Publikováno v:
Oral oncology [Oral Oncol] 2018 Jul; Vol. 82, pp. 144-151. Date of Electronic Publication: 2018 May 28.
Autor:
Romeo P; Molecular Mechanisms UnitResearch Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Colombo C; Division of Endocrine and Metabolic DiseasesIRCCS Istituto Auxologico Italiano, Milan, Italy.; Department of Pathophysiology and TransplantationUniversity of Milan, Milan, Italy., Granata R; Department of Head and Neck Medical OncologyFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Calareso G; Department of RadiologyFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gualeni AV; Department of Diagnostic Pathology and Laboratory MedicineFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dugo M; Functional Genomics and Bioinformatics UnitDepartment of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Functional Genomics and Bioinformatics UnitDepartment of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Rizzetti MG; Molecular Mechanisms UnitResearch Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Zanframundo A; Department of Diagnostic Pathology and Laboratory MedicineFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Aiello A; Department of Diagnostic Pathology and Laboratory MedicineFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Carcangiu ML; Department of Diagnostic Pathology and Laboratory MedicineFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gloghini A; Department of Diagnostic Pathology and Laboratory MedicineFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ferrero S; Department of Pathophysiology and TransplantationFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of BiomedicalSurgical and Dental Sciences, University of Milan, Milan, Italy., Licitra L; Department of Head and Neck Medical OncologyFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Medical OncologyUniversity of Milan, Milan, Italy., Greco A; Molecular Mechanisms UnitResearch Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fugazzola L; Division of Endocrine and Metabolic DiseasesIRCCS Istituto Auxologico Italiano, Milan, Italy.; Department of Pathophysiology and TransplantationUniversity of Milan, Milan, Italy., Locati LD; Department of Head and Neck Medical OncologyFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy mariagrazia.borrello@istitutotumori.mi.it laura.locati@istitutotumori.mi.it., Borrello MG; Molecular Mechanisms UnitResearch Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy mariagrazia.borrello@istitutotumori.mi.it laura.locati@istitutotumori.mi.it.
Publikováno v:
Endocrine-related cancer [Endocr Relat Cancer] 2018 Mar; Vol. 25 (3), pp. 217-231. Date of Electronic Publication: 2018 Jan 03.
Autor:
Arrighetti N; Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: Noemi.Arrighetti@istitutotumori.mi.it., Cossa G; Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: Gia.Cossa@gmail.com., De Cecco L; Functional Genomics and Bioinformatics, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: Loris.Dececco@istitutotumori.mi.it., Stucchi S; Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: Simone.Stucchi@istitutotumori.mi.it., Carenini N; Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: Nives.Carenini@istitutotumori.mi.it., Corna E; Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: Elisabetta.Corna@istitutotumori.mi.it., Gandellini P; Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: Paolo.Gandellini@istitutotumori.mi.it., Zaffaroni N; Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: Nadia.Zaffaroni@istitutotumori.mi.it., Perego P; Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: paola.perego@istitutotumori.mi.it., Gatti L; Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: Laura.Gatti@istitutotumori.mi.it.
Publikováno v:
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2016 Nov 01; Vol. 310, pp. 9-19. Date of Electronic Publication: 2016 Aug 20.
Autor:
Bagnoli M; Molecular Therapies Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Canevari S; Functional Genomics, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Califano D; Functional Genomic Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione G Pascale', IRCCS, Naples, Italy., Losito S; Surgical Pathology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione G Pascale', IRCCS, Naples, Italy., Maio MD; Clinical Trials Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione G Pascale', IRCCS, Naples, Italy., Raspagliesi F; Unit of Gynaecological Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Carcangiu ML; Anatomic Pathology 1 Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Toffoli G; Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico, Istituto Ricovero e Cura Carattere Scientifico (CRO-IRCCS), Aviano, Italy., Cecchin E; Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico, Istituto Ricovero e Cura Carattere Scientifico (CRO-IRCCS), Aviano, Italy., Sorio R; Medical Oncology C, Centro di Riferimento Oncologico, Istituto Ricovero e Cura Carattere Scientifico (CRO-IRCCS), Aviano, Italy., Canzonieri V; Unit of Pathology, Centro di Riferimento Oncologico, Istituto Ricovero e Cura Carattere Scientifico (CRO-IRCCS), Aviano, Italy., Russo D; Functional Genomic Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione G Pascale', IRCCS, Naples, Italy., Scognamiglio G; Surgical Pathology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione G Pascale', IRCCS, Naples, Italy., Chiappetta G; Functional Genomic Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione G Pascale', IRCCS, Naples, Italy., Baldassarre G; Division of Experimental Oncology 2, Centro di Riferimento Oncologico, Istituto Ricovero e Cura Carattere Scientifico (CRO-IRCCS), Aviano, Italy., Lorusso D; Unit of Gynaecological Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Scambia G; Department of Obstetrics and Gynecology, Gynecologic Oncology Unit, Catholic University of the Sacred Heart, Rome, Italy., Zannoni GF; Department of Human Pathology, Division of Gynecologic Pathology, Catholic University of the Sacred Heart, Rome, Italy., Savarese A; Division of Medical Oncology 1, Regina Elena Cancer Institute, Rome, Italy., Carosi M; Division of Pathology, Regina Elena Cancer Institute, Rome, Italy., Scollo P; Department of Obstetrics and Gynecology, Azienda Ospedaliera Cannizzaro, Catania, Italy., Breda E; Medical Oncology Unit Ospedale S Giovanni Calibita Fatebenefratelli, Rome, Italy., Murgia V; Medical Oncology Unit Ospedale S Chiara, Trento, Italy., Perrone F; Clinical Trials Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione G Pascale', IRCCS, Naples, Italy., Pignata S; Department of Urogynaecological Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione G Pascale', IRCCS, Naples, Italy., De Cecco L; Functional Genomics, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Mezzanzanica D; Molecular Therapies Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: delia.mezzanzanica@istitutotumori.mi.it.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2016 Aug; Vol. 17 (8), pp. 1137-1146. Date of Electronic Publication: 2016 Jul 09.
Autor:
Minna E; Department of Experimental Oncology and Molecular Medicine, Molecular Mechanisms Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Romeo P; Department of Experimental Oncology and Molecular Medicine, Molecular Mechanisms Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dugo M; Department of Experimental Oncology and Molecular Medicine, Functional Genomics Core Facility, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Department of Experimental Oncology and Molecular Medicine, Functional Genomics Core Facility, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Todoerti K; Laboratory of Pre-Clinical and Translational Research, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy., Pilotti S; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Perrone F; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Seregni E; Department of Diagnostic Imaging and Radiotherapy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Agnelli L; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Neri A; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy., Greco A; Department of Experimental Oncology and Molecular Medicine, Molecular Mechanisms Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Borrello MG; Department of Experimental Oncology and Molecular Medicine, Molecular Mechanisms Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Oncotarget [Oncotarget] 2016 Mar 15; Vol. 7 (11), pp. 12731-47.
Autor:
Vergani E; Immunotherapy Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Di Guardo L; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dugo M; Functional Genomics and Bioinformatics Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Rigoletto S; Immunotherapy Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tragni G; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ruggeri R; Melanoma and Sarcoma Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Perrone F; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tamborini E; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gloghini A; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Arienti F; Immunohematology and Transfusion Medicine Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Vergani B; Consorzio MIA, Microscopy and Image Analysis, University of Milan Bicocca, Monza, Italy., Deho P; Immunotherapy Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Functional Genomics and Bioinformatics Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Vallacchi V; Immunotherapy Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Frati P; Immunotherapy Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Shahaj E; Immunotherapy Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Villa A; Consorzio MIA, Microscopy and Image Analysis, University of Milan Bicocca, Monza, Italy., Santinami M; Melanoma and Sarcoma Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Braud F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Rivoltini L; Immunotherapy Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Rodolfo M; Immunotherapy Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Oncotarget [Oncotarget] 2016 Jan 26; Vol. 7 (4), pp. 4428-41.